NCT00201773 - Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2011

Conditions

Breast Cancer

Interventions

DRUG

Exemestane

25 mg orally once per day for 16 weeks.

DRUG

Celecoxib

given orally at two 200 mg capsules (400 mg) twice per day. Patients assigned to receive 400 mg twice per day should be instructed to take the drug with food.

OTHER

Correlative studies

Trial Locations (1)

43210

Ohio State University, Columbus